BD a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, announced a framework collaboration agreement...
AbbVie and Neomorph, announced a collaboration and option-to-license agreement to develop novel molecular glue degraders for multiple targets across oncology and immunology.
Molecular glue degraders...
Charles River Laboratories International, Inc. and Akron Bio, a leading supplier of critical materials and services for advanced therapies, announced the integration of Akron’s...
Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, announced the appointment of Matthew E. Ros as...
